genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2022
Samsung Bioepis
Bioprocessing
Biogen Poised for Pipeline Growth, Samsung Eyes New Drug Expansion after $2.3B Joint Venture Deal
Drug Discovery
Takeda, Samsung Bioepis Partner to Develop Novel Biologic Therapies
Drug Discovery
Merck, Samsung Bioepis Launch Remicade Biosimilar in U.S.
News
Thermo and Samsung Join Forces to Advance Point-of-Care Dx
Bioprocessing
EMD Millipore Inks Biomanufacturing Deal with Samsung BioLogics
News
Merck, Samsung Bioepis Expand Collaboration with Diabetes in Mind
Drug Discovery
Biogen Idec, Samsung Bioepis to Commercialize Anti-TNF Biosimilars in Europe
Bioprocessing
Samsung Biologics, BMS in Manufacturing Partnership
Drug Discovery
Electronics Giant Samsung Makes First Big Biotech Play
Drug Discovery
Biogen Idec, Samsung Establish $300M Biosimilar Joint Venture
Scroll Up
Scroll Up
